MedPath

The effectiveness of the placement of gold markers for irradiation of rectal cancer.

Completed
Conditions
Rectal cancerRectumcarcinoomEndeldarmkanker
Registration Number
NL-OMON20605
Lead Sponsor
KI-AV
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

•Histologically proven diagnosis of primary rectal adenocarcinoma

•Resectable rectal cancer

Exclusion Criteria

•Coagulopathy (prothrombin time < 50% of control; partial thromboplastin time > 50 seconds) or anticoagulantia (marcoumar or sintrom) that cannot be stopped

•Prior pelvic irradiation or surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The feasibility of fiducial marker placement, defined as the technical success (the ability to successfully place the fiducials at the desired locations in the tumour area).<br>
Secondary Outcome Measures
NameTimeMethod
- Patient safety: grade 3-4 complications (NCI-CTCAE version 4.0) or symptoms lasting more than two days.<br /><br>- Visibility of fiducial markers on MRI and CT<br /><br>- Migration of fiducial markers
© Copyright 2025. All Rights Reserved by MedPath